Literature DB >> 11719180

Thrombolysis with recombinant tissue plasminogen activator during cardiopulmonary resuscitation in fulminant pulmonary embolism. A case series.

M Ruiz-Bailén1, E Aguayo-de-Hoyos, M C Serrano-Córcoles, M A Díaz-Castellanos, J L Fierro-Rosón, J A Ramos-Cuadra, M Rodríguez-Elvira, J M Torres-Ruiz.   

Abstract

OBJECTIVE: To describe our outcomes using thrombolysis during the cardiopulmonary resuscitation (CPR) of patients in cardiorespiratory arrest (CA) caused by fulminant pulmonary embolism (FPE).
DESIGN: A case series.
SETTING: Intensive care units of a district hospital and a referral centre. PATIENTS: Six patients that suffered CA secondary to an FPE.
INTERVENTIONS: Administration of recombinant tissue plasminogen activator during usual CPR manoeuvres when there was a strong suspicion of FPE. Permission for the thrombolytic therapy was sought from family members in all cases.
RESULTS: Four out of the six patients survived and remain symptom-free. The thrombolysis was not associated with any fatal complications.
CONCLUSIONS: Early thrombolysis during CPR manoeuvres for CA apparently caused by an FPE may reduce the mortality rate among these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11719180     DOI: 10.1016/s0300-9572(01)00384-7

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  8 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  Pediatric In-Hospital Cardiac Arrest Secondary to Acute Pulmonary Embolism.

Authors:  Ryan W Morgan; Hannah R Stinson; Heather Wolfe; Robert B Lindell; Alexis A Topjian; Vinay M Nadkarni; Robert M Sutton; Robert A Berg; Todd J Kilbaugh
Journal:  Crit Care Med       Date:  2018-03       Impact factor: 7.598

Review 3. 

Authors:  J P Nolan; C D Deakin; J Soar; B W Böttiger; G Smith; M Baubin; B Dirks; V Wenzel
Journal:  Notf Rett Med       Date:  2006-02-01       Impact factor: 0.826

4.  Giant right atrial thrombi treated with thrombolysis.

Authors:  Manuel Ruiz-Bailén; Carmen López-Caler; Ana Castillo-Rivera; Luis Rucabado-Aguilar; José Angel Ramos Cuadra; Juan Lara Toral; Cristobal Lozano Cabezas; Juan Carlos Fernández Guerrero
Journal:  Can J Cardiol       Date:  2008-04       Impact factor: 5.223

Review 5.  Safety of thrombolysis during cardiopulmonary resuscitation.

Authors:  Fabian Spöhr; Bernd W Böttiger
Journal:  Drug Saf       Date:  2003       Impact factor: 5.228

6.  Thrombolytic treatment (alteplase; rt-Pa) in acute massive pulmonary embolism and cardiopulmonary arrest.

Authors:  Adem Dirican; Sevket Ozkaya; Ali Ekber Atas; Esra Kayahan Ulu; Ilknur Kitapci; Ferah Ece
Journal:  Drug Des Devel Ther       Date:  2014-06-12       Impact factor: 4.162

7.  Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium.

Authors:  Belinda Rivera-Lebron; Michael McDaniel; Kamran Ahrar; Abdulah Alrifai; David M Dudzinski; Christina Fanola; Danielle Blais; David Janicke; Roman Melamed; Kerry Mohrien; Elizabeth Rozycki; Charles B Ross; Andrew J Klein; Parth Rali; Nicholas R Teman; Leoara Yarboro; Eugene Ichinose; Aditya M Sharma; Jason A Bartos; Mahir Elder; Brent Keeling; Harold Palevsky; Soophia Naydenov; Parijat Sen; Nancy Amoroso; Josanna M Rodriguez-Lopez; George A Davis; Rachel Rosovsky; Kenneth Rosenfield; Christopher Kabrhel; James Horowitz; Jay S Giri; Victor Tapson; Richard Channick
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

Review 8.  Management dilemmas in acute pulmonary embolism.

Authors:  Robin Condliffe; Charlie A Elliot; Rodney J Hughes; Judith Hurdman; Rhona M Maclean; Ian Sabroe; Joost J van Veen; David G Kiely
Journal:  Thorax       Date:  2013-12-16       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.